ml8b00215_si_001.pdf (1.54 MB)
Lead Optimization of 5‑Aryl Benzimidazolone- and Oxindole-Based AMPA Receptor Modulators Selective for TARP γ‑8
journal contribution
posted on 2018-07-13, 00:00 authored by Suchitra Ravula, Brad M. Savall, Nyantsz Wu, Brian Lord, Kevin Coe, Kai Wang, Mark Seierstad, Devin M. Swanson, Jeannie Ziff, Minh Nguyen, Perry Leung, Ray Rynberg, David La, Daniel J. Pippel, Tatiana Koudriakova, Timothy W. Lovenberg, Nicholas I. Carruthers, Michael P. Maher, Michael K. AmeriksGlutamate
mediates fast excitatory neurotransmission via ionotropic
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)
receptors. The trafficking and gating properties of AMPA receptors
(AMPARs) can be amplified by transmembrane AMPAR regulatory proteins
(TARPs), which are often expressed in localized brain regions. Herein,
we describe the discovery, lead optimization, and preclinical characterization
of 5-arylbenzimidazolone and oxindole-based negative modulators of
AMPARs associated with TARP γ-8, the primary TARP found in hippocampus.
High-throughput screen lead 4 was optimized for potency
and brain penetration to provide benzimidazolone 3, JNJ-55511118. Replacement of the benzimidazolone core in 3 with an oxindole mitigated reactive metabolite formation
and led to the identification of 18 (GluA1/γ-8
pIC50 = 9.7). Following oral dosing in rats, 18 demonstrated robust target engagement in hippocampus as assessed
by ex vivo autoradiography (ED50 = 0.6
mg/kg, plasma EC50 = 9 ng/mL).
History
Usage metrics
Categories
Keywords
benzimidazolone 3transmembrane AMPARAMPA receptorsLead Optimizationvivo autoradiographybrain regionsECionotropic α-High-throughput screenJNJ -55511118. ReplacementOxindole-Based AMPA Receptor Modulators5- arylbenzimidazolonebenzimidazolone coreoxindole mitigated reactive metabolite formationhippocampu-3-hydroxy acidgating propertiesED 50brain penetrationTARPtarget engagement
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC